Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The 30mg vial is double the size of the standard 15mg presentation and is suited to research protocols that benefit from a larger working stock at the same 10mg/mL concentration
Patients on multiple anticonvulsants, children, those with congenital metabolic disorders, those with severe seizure disorders accompanied by mental retardation, and those with organic brain disease may be at particular risk
Some people notice improved energy and mental clarity within days
Patients with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease should avoid Retatrutide
Proper screening, dosing adjustments, and side-effect monitoring reduce risk and improve outcomes
US$ 29.83
US$ 24.44
US$ 22.17
US$ 26.76
US$ 29.87
US$ 22.05
